文献速递免疫规划妇幼与学校卫生

妊娠期暴露于MenACWY-CRM疫苗的安全性

Safety of MenACWY-CRM vaccine exposure during pregnancy.
PubMed 文献 · Vaccine · 2020-02-10

研究纳入2011年9月30日至2013年6月30日期间在Kaiser Permanente南加州医疗机构11-21岁无意中于受孕前28天内或妊娠期接种MenACWY-CRM疫苗的孕妇,通过病历摘录识别妊娠和出生结局。66例已知妊娠结局中自然流产发生率为18.2%,55例活产儿中早产占14.5%、低出生体重占9.1%、主要先天性畸形占1.8%。作者认为这些估计值与美国背景患病率估计值似乎相当。

要点

  • 92名孕妇在受孕前28天内或妊娠期无意接种MenACWY-CRM,76.1%发生在孕早期。
  • 已知妊娠结局66例中自然流产12例,发生率18.2%。
  • 活产儿55例中早产8例(14.5%)、低出生体重5例(9.1%)、主要先天性畸形1例(1.8%)。

核心结论

  • 本研究提供了妊娠期无意暴露于MenACWY-CRM后自然流产、早产、低出生体重和主要先天性畸形的基线患病率估计值,这些估计值似乎与美国背景患病率估计值相当。

研究设计与样本

  • 研究人群为Kaiser Permanente南加州医疗机构的妊娠女性成员,于2011年9月30日至2013年6月30日期间在11-21岁时无意中在受孕前28天内或妊娠期接种MenACWY-CRM疫苗。
  • 通过病历摘录识别妊娠和出生结局,包括自然流产和人工流产、早产、低出生体重和主要先天性畸形(MCMs)。

主要发现

  • 共有92名女性在妊娠暴露期接种MenACWY-CRM,主要发生在孕早期(76.1%)。
  • 西班牙裔占最大种族/族裔类别(68.5%)。
  • 在已知妊娠结局中(n=66;排除人工流产和未知妊娠结局),自然流产发生率为18.2%(n=12)。
  • 在活产婴儿中(n=55;来自54次妊娠),14.5%(n=8)为早产(<37周妊娠),9.1%(n=5)为低出生体重(<2500 g)。
  • 活产婴儿(n=55)中主要先天性畸形的患病率为1.8%(n=1)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although the meningococcal conjugate MenACWY-CRM vaccine is not approved for use in pregnant women, unintentional exposure during pregnancy can occur, especially during early pregnancy among women of child-bearing age. This study provides safety information about inadvertent MenACWY-CRM vaccination during pregnancy. METHODS: The evaluated population consisted of pregnant female members of Kaiser Permanente Southern California who inadvertently received MenACWY-CRM at 11-21 years of age during 09/30/2011-06/30/2013 within 28 days prior to conception or during pregnancy. Chart abstraction was conducted to identify pregnancy and birth outcomes, including spontaneous and induced abortions, preterm births, low weight births, and major congenital malformations (MCMs). RESULTS: There were 92 women who received MenACWY-CRM during the pregnancy exposure period, mainly during the first trimester (76.1%). Hispanics represented the largest race/ethnicity category (68.5%). Among the known pregnancy outcomes (n = 66; excluding induced abortions and unknown pregnancy outcomes), the prevalence of spontaneous abortions was 18.2% (n = 12). Among live born infants (n = 55; from 54 pregnancies), 14.5% (n = 8) were born preterm (<37 weeks gestation) and 9.1% (n = 5) had a low birthweight (<2500 g). The prevalence rate of MCMs among live born infants (n = 55) was 1.8% (n = 1). CONCLUSIONS: This study provides baseline prevalence estimates of spontaneous abortions, preterm births, low weight births, and MCMs among women inadvertently exposed to MenACWY-CRM during the pregnancy period. These estimates appear to be comparable with U.S. background prevalence estimates.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Becerra-Culqui TA, Sy LS, Ackerson BK, et al. Safety of MenACWY-CRM vaccine exposure during pregnancy. Vaccine. 2020. PMID: 32057568. doi:10.1016/j.vaccine.2020.02.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。